Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 01, 2015 6:39 PM ET


Company Overview of APT Pharmaceuticals, Inc.

Executive Profile

Sue Barrowcliffe BSc

Global Head of Regulatory Affairs and Executive Vice President of Development - Europe, APT Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships


Ms. Sue Barrowcliffe, BSc, serves as Pre-Clinical and Clinical Advisor of Cellzome AG. Ms. Barrowcliffe serves as Consultant of Regulatory Affairs of Pharminox Ltd. Ms. Barrowcliffe serves as the Global Head of Regulatory Affairs and Executive Vice President of Development Europe of APT Pharmaceuticals, Inc. Ms. Barrowcliffe has over 20 years experience in global drug development and regulatory affairs obtained in both large and small companies. She served as Vice President ...

Corporate Headquarters

700 Airport Boulevard
Burlingame, California 94010

United States

Phone: 650-931-1666
Fax: 650-931-1667

Board Members Memberships

Non Executive Director


Bachelor's Degree
The University of Sheffield

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact APT Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at